BioSpace.com News

Helix Biopharma Announces Q3 Fiscal 2013 Results

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AURORA, ON--(Marketwired - June 18, 2013) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical...

PerkinElmer, Inc. Board Declares Quarterly Dividend

Fri, 14 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on June 13, 2013. This dividend is payable on August 9, 2013, to all shareholders...

PURE Bioscience Reports Fiscal Third Quarter 2013 Results

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, CA--(Marketwired - June 14, 2013) - PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented...

PDL BioPharma, Inc. Completes Regular Quarterly Dividend Payment

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

INCLINE VILLAGE, Nev., June 12, 2013 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it...

PDL BioPharma, Inc. Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million

Wed, 12 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

INCLINE VILLAGE, Nev., June 11, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced royalty...

Enzo Biochem Reports Third Quarter Results

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal third quarter ended April 30, 2013. Among the quarters highlights:

Sequential revenues growth, gross margin improvement and reduced...

Polydex Pharmaceuticals Issues First Quarter Financial Results

Mon, 10 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO, June 10, 2013 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the "Company") reports financial results for the first quarter of fiscal 2014, the three-month period ending April...

Enzo Biochem Schedules Teleconference to Discuss Third Quarter Results on June 11, 2013 at 8:30 AM E.T.

Fri, 07 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2013 third quarter results on Tuesday, June 11, 2013, at 8:30 AM E.T. To listen to the conference call...

Nordion Reports Second Quarter Fiscal 2013 Financial Results

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Nordion Inc.(TSX: NDN) (NYSE: NDZ):

Revenue of $56.1 million in Q2 2013, an increase of 12% over Q2 2012

Adjusted loss per share, excluding specified items, of $0.03 in Q2 2013, down from...

Cegedim SA: Improvement on Profitability on the First Quarter

Wed, 05 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Cegedim, a global technology and services company specializing in the healthcare field, posted consolidated first quarter 2013 revenues of 212.9 million, down 0.6% on a reported...

GW Pharmaceuticals Reports 2013 Second Quarter Financial Results

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LONDON, June 3, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel...

Patheon Inc. Reports Fiscal 2013 Second Quarter Results

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO, June 3, 2013 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, with recently acquired proprietary...

Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter FY2013

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its third fiscal quarter of...

MGC Diagnostics Corporation Reports 2013 Second Quarter Operating Results

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAINT PAUL, Minn., May 30, 2013 /PRNewswire/ -- MGC Diagnostics Corporation MGCD (formerly Angeion Corporation), a global medical technology company, today reported financial results for the second quarter ended...

Bio-Reference Laboratories Announces Earnings Date for Second Quarter for Fiscal Year 2013

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ELMWOOD PARK, N.J., May 30, 2013 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the second quarter of fiscal 2013 before the open of...

Hill-Rom, Inc. Increases Third Quarter 2013 Dividend

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BATESVILLE, Ind., May 29, 2013 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its board of...

Kewaunee Scientific Corporation Declares Quarterly Dividend

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STATESVILLE, N.C., May 29, 2013 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU...

Proteome Sciences PLC Release Preliminary Results for the Year Ended 31st December, 2012

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

30th May, 2012 -- Highlights:

Commercial

— Revenue increased 13% to 1.15m

— Licences / Sales / Services showed 22% growth

— TMT revenue grew sharply with reagent...

Merck & Co., Inc. Announces Third-Quarter 2013 Dividend

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.43 per share on the companys common stock for the third quarter...

Nordion to Release Second Quarter 2013 Financial Results

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Nordion Inc. (TSX: NDN; NYSE: NDZ), a leading provider of products and services to the global health science market, today announced that the Company is scheduled to report its second quarter 2013 financial...

Pivotal Therapeutics Inc. Announces First Quarter 2013 Financial Results

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WOODBRIDGE, ON, May 29, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty...

Questcor Pharmaceuticals, Inc. (Headquarters) Announces Quarterly Dividend

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ANAHEIM, Calif., May 29, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that its Board of Directors...

NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2013 till 31 Mar. 2013

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

The listing on Nasdaq OMX creates possibilities for the future

After NeuroVives IPO on NASDAQ OMX Stockholm Small Cap in April, the company has secured prospects for...

Organovo Reports Fiscal 2013 Financial Results

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, May 28, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has reported on its...

Omthera Pharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PRINCETON, N.J., May 28, 2013 /PRNewswire/ -- Omthera Pharmaceuticals, Inc. (Nasdaq: OMTH), an emerging specialty pharmaceutical...

Sinovac Biotech Ltd. Reports Unaudited First Quarter 2013 Financial Results

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEIJING, May 28, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period...

Taro Pharmaceutical Industries Ltd. Provides Results Year Ended March 31, 2013

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today provided unaudited financial results for the three months and year ended March 31, 2013.

Quarter ended March 31, ...

Alkermes plc Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Alkermes plc (NASDAQ: ALKS) today reported financial results for its fourth quarter and fiscal year ended March 31, 2013. The company also announced that it has changed its fiscal year-end from March 31 to Dec...

Phytopharm PLC Interim Results for the Six Months Ended 31 March 2013

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

23 May 2013 -- Phytopharm plc (PYM: London Stock Exchange) (Phytopharm or the Company or the Group) today announces its unaudited interim results for the six months ended 31 March 2013.

On the...

Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH EASTON, Mass., May 23, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"...

Thermo Fisher Scientific Declares Quarterly Dividend

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid...

Analogic Corporation Announces Timing for Third Quarter Fiscal 2013 Earnings Conference Call and Webcast

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PEABODY, Mass., May 21, 2013 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG) announced today that it will conduct a conference call on Tuesday, June 4, 2013, at 5:00 p.m. (ET) to discuss results for the...

Acasti Pharma Announces Fiscal 2013 Results and Provides Update on Status of Clinical Trials

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAVAL, Quebec, May 22, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary, announces its consolidated...

Concord Medical Services Holdings Limited Reports First Quarter 2013 Financial Results

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEIJING, May 21, 2013 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") CCM, a leading specialty hospital management solution provider and operator of the largest...

Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January ??? March 2013

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Moberg Pharma AB (publ) (STO:MOB)

Continued Strong Growth - Moberg Derma Becomes Moberg Pharma

FIRST QUARTER (JAN-MAR 2013)

Revenue MSEK 38...

Pressure BioSciences, Inc. Reports Strong First Quarter 2013 Financial Results

Tue, 21 May 2013 12:00:00 AM GMT

SOUTH EASTON, MA--(Marketwired - May 21, 2013) - Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the three-month period ended March 31, 2013 and provided a business update.

Total revenue for the first quarter of 2013 was $370,737 compared to...

Uroplasty, Inc. to Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results on May 30, 2013

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MINNEAPOLIS, May 20, 2013 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI) announced today...

EpiCept Corporation Reports First Quarter 2013 Operating and Financial Results

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) todayannounced operating and financial results for the three months ended March 31,2013, and provided an update on the Companys planned...

PuriCore Interim Management Statement

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 17, 2013 -- PuriCore (LSE: PURI), the water-based clean technology company, today announces its Interim Management Statement for the period from 1 January 2013 to 17 May 2013 (which incorporates information...

SciClone Pharmaceuticals, Inc. Reports Anticipated Financial Results for the First Quarter 2013

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FOSTER CITY, CA--(Marketwired - May 16, 2013) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported...

Taro Pharmaceutical Industries Ltd. to Announce Results for Year Ended March 31, 2013

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro) announced today that it plans to release its financial results for the quarter and year ended March 31, 2013 after market close on Thursday, May 23...

Senesco Technologies, Inc. Reports Second Quarter Fiscal 2013 Financial Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Senesco Technologies, Inc. (Senesco or the Company) (OTCQB: SNTI) today reported financial results for the third quarter of fiscal year 2013 which ended on March 31, 2013.

Highlights of the third...

Access Pharmaceuticals Reports First Quarter Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DALLAS and NEW YORK, May 16, 2013 /PRNewswire/ --

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) and Astellas Pharma Inc. Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced that additional data from the Phase 3 TIVO-1 trial (TIvozanib Versus sOrafenib in 1st line advanced RCC) of investigational agent...

Aoxing Pharmaceutical Company Inc. Announces Financial Results for Third Quarter Of 2013 Fiscal Year

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

JERSEY CITY, N.J., May 15, 2013 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma...

Bio-Path Holdings, Inc. Reports First Quarter 2013 Operational and Financial Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Bio-Path Holdings, Inc., (OTCQX: BPTH) (Bio-Path), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the...

Catalyst Pharmaceutical Partners, Inc. Reports First Quarter 2013 Financial Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CORAL GABLES, Fla., May 16, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel prescription...

Derma Sciences, Inc. Reports First Quarter 2013 Financial Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three months ended March 31, 2013. Highlights...

Dyadic International, Inc. Reports First Quarter 2013 Financial Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

JUPITER, Fla., May 15, 2013 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company, today announced financial results for the quarter ended March 31, 2013.

Dyadic...

DelMar Pharmaceuticals Provides Corporate Update for the Quarter Ended March 31, 2013

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2013 /PRNewswire/ -- DelMar...

Isotechnika Pharma Inc. Reports First Quarter 2013 Financial Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EDMONTON, Alberta, May 15, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") has released its financial results for the first quarter ended March 31, 2013.

Help employers...

Pharmagen Announces First Quarter 2013 Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SILVER SPRING, Md., May 15, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCBB: PHRX) (the "Company" or "Pharmagen") today announced...

RBC Life Sciences, Inc. Reports First Quarter 2013 Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

IRVING, Texas, May 15, 2013 /PRNewswire/ -- RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated...

Source BioScience Interim Management Statement

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

16 May 2013 -- Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis services business, today publishes its Interim Management Statement for the year to date.

Unless otherwise...

Talon Therapeutics, Inc. Reports First Quarter 2013 Financial Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., May 15, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCQB:TLON), today reported financial results for the three months ended March 31, 2013.

Help employers find...

Targeted Medical Pharma Reports 2013 First Quarter Results

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today...

Veloxis Pharmaceuticals A/S Announces Financial Results for the First Three Months of 2013

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HORSHOLM, Denmark, May 15, 2013 /PRNewswire/ --

Highlights:

On 29 April, 2013 Veloxis submitted the MAA to the European Medicines Agency (EMA) seeking approval to market LCP-Tacro for...

Waters Corporation Presentation at the UBS 2013 Global Healthcare Conference to be Webcast Live

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Waters Corporation (NYSE:WAT) John Ornell, Chief Financial Officer, will speak to the investment community at the UBS 2013 Global Healthcare Conference at the Sheraton New York Hotel in New York City on Tuesday...

Athersys, Inc. Reports First Quarter 2013 Results